Press Releases

A large, national labor union will pay Sutter Health $6 million and has formally apologized for sending false and disparaging postcards to consumers in numerous communities served by Sutter-affiliated hospitals and birthing centers. The apology...

Peter Zerhouni has been involved in all aspects of the Company since 2006 and he is since April 2011 Acting President and CEO of the Company. He assumes his position as President and CEO of Diamyd Medical AB on...

Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved three products - GARDASIL® , ZOLINZA® (vorinostat) and CUBICIN® (daptomycin for injection) – for...

CiToxLAB, a leading CRO in the field of non-clinical research, announces today that Paul C. Barrow has joined the company after serving ten years as a director of toxicology at Ricerca Biosciences. Barrow has more than...

Alkermes, Inc. (NASDAQ: ALKS) today announced positive topline results from a phase 1b, double-blind, randomized, placebo-controlled study of ALKS 9070 in patients with schizophrenia. ALKS 9070, a proprietary Alkermes molecule for the treatment of...

Provence Technologies, a service provider in fine organic chemistry, and NexGenix Pharmaceuticals, a discovery and development company focused on the "next generation" of targeted therapies for cancer and diseases of the nervous system, announce today a successful collaboration for...

Adocia SAS, a privately-held biotechnology company specialized in regenerative medicine and in the treatment of chronic diseases, announced today the launch of its second clinical trial for the development of HinsBet(R), its fast-acting human insulin. ...